Creative Medical Technology Holdings, Inc. (CELZ) Q1 2026 Annual Earnings
CELZ·Reported May 8, 2026·After market close
Diluted EPS came in at $-0.38 (+54.2% YoY), beat the $-0.39 consensus by $0.01.
Diluted EPS
$-0.38beat by $0.01
Consensus: $-0.39
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Creative Medical Technology Holdings, Inc.'s Q1 2026 earnings report.
Creative Medical Technology Holdings, Inc. (CELZ) reported Q1 2026 earnings on May 8, 2026 after market close.
Creative Medical Technology Holdings, Inc. reported diluted EPS of $-0.38 for Q1 2026.
EPS beat the consensus estimate of $-0.39 by $0.01.
Compared to the same quarter a year prior, diluted EPS grew 54.2% from $-0.83.
You can read the 10-K/A periodic report (0001477932-26-002534) directly on SEC EDGAR. The filing index links above go to sec.gov.